Log in to save to my catalogue

Acetazolamide: Old drug, new evidence?

Acetazolamide: Old drug, new evidence?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1815993a8361484092c18d0aba80435d

Acetazolamide: Old drug, new evidence?

About this item

Full title

Acetazolamide: Old drug, new evidence?

Publisher

United States: John Wiley & Sons, Inc

Journal title

Epilepsia open, 2022-09, Vol.7 (3), p.378-392

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Acetazolamide is an old drug used as an antiepileptic agent, amongst other indications. The drug is seldom used, primarily due to perceived poor efficacy and adverse events. Acetazolamide acts as a noncompetitive inhibitor of carbonic anhydrase, of which there are several subtypes in humans. Acetazolamide causes an acidification of the intracellula...

Alternative Titles

Full title

Acetazolamide: Old drug, new evidence?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1815993a8361484092c18d0aba80435d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1815993a8361484092c18d0aba80435d

Other Identifiers

ISSN

2470-9239

E-ISSN

2470-9239

DOI

10.1002/epi4.12619

How to access this item